Figures and data
Generation of anti-N2 sera panel from ferrets and mice.
(a) 43 Ferret immunization and blood sampling scheme. The second immunization on day 28 was performed with homologous NACHO except for the ferrets that had been primed with H1N2A/Estonia/91621/2015 or H1N2A/Stockholm/15/2014, which were infected again on day 28 post prime with the same H1N2 viruses. (b) Homologous NACHO ELISA titer of ferret sera sampled on day 14 after inoculation with H1N2 virus and 2 weeks after the boost with recombinant NA or by re-inoculation with H1N2A/Estonia/91621/2015 or H1N2A/Stockholm/15/2014 (indicated by arrows on the X-axis). (c) 43 BALB/c mouse immunization and blood sampling scheme. (d) Homologous NACHO serum IgG titers in pooled sera from mice that were immunized twice with recombinant NA. Mouse and ferrets representations were created with BioRender.com (2023).
© 2024, BioRender Inc. Any parts of this image created with BioRender are not made available under the same license as the Reviewed Preprint, and are © 2024, BioRender Inc.
Breadth of N2 NA inhibition.
43 Phylogenetic tree based on the N2 NA head domain amino acid sequences and heat-map representing the average of normalized neuraminidase inhibition per H6N2 [log2 (max (NAI/ ELISA homologous titer)/(NAI/ homologous ELISA titer)] determined in ferret sera after the boost (listed vertically). The red-to-blue scale indicates high-to-low NAI observed in ELLA against the H6N2 reassortants (listed at the bottom). UPGMA clustering of H6N2s inhibition profiles are shown on top of the heat map and coloured according to the phylogenetic groups.
Association analysis reveals impact of amino acid mutations on NAI.
(a) Association study performed for each H6N2 virus (listed at the bottom) to determine the probability of each variable amino acid (listed on the right) present in the panel of 43 NAs to impact the NAI. The red-to-blue scale represents significance values (S=-log10P) associated with each amino acid substitution. The dark red in the color scale represent all values that are equal or higher than 3 (corresponding to p-values ≤ 0.001). The colour shades on the bottom side indicate the distinct phylogenetic groups. (b) The significant values (p<0.05) were represented on the surface of N2 tetramer (PDB accession number 4H53) for one representative strain of each phylogenetic group with a yellow to red scale of significance (-log10P).
Residues close to the catalytic pocket are more likely to impact NAI.
(a) Significance values (102 variable amino acids) obtained from the association study were correlated to the distance between every amino acid and each of the variable amino acids in the NA structure. The red-to-blue scale represents the Tau values obtained in the Kendall correlation. Amino acids 83 to 469 are shown from top to bottom in the heatmap. The H6N2s used in the NAI panel are listed at the bottom. The grey column indicates the residues that are part of the catalytic pocket (CP) that directly interact with the substrate (R118, D151, R152, R224, E276, R292, R371, and Y406) and the residues that play a key role in stabilizing the catalytic site (E119, R156, W178, S179, D198, I222, E227, H274, E277, N294, and E425). (b) Tau values obtained from Tex12 H6N2 correlation are represented on the surface of the N2 structure of A/RI/5+/1957 (PBD 4H53), the arrow indicates the catalytic pocket in one NA protomer.
Prediction of N2 antigenicity based on machine learning.
(a) Predicted vs observed normalized NAIs are shown. (b) Multi-way importance plot indicating the increase in mean standard error, the mean depth, and number of nodes. The top 10 most important amino acid changes are highlighted in blue and annotated with their position in the NA sequence. (c) 43 The heatmap indicates the predicted antigenic distances of N2s from recent H3N2 isolates (at the bottom of the heatmap) relative to the N2s that were used in the NAI breadth panel (listed vertically). The antigenic distances were calculated based on NA protein sequence.
The N2 NA substrate affinity is distinct in the N2 phylogenetic groups.
(a) KM was determined for each H6N2 reassortant virus using the fluorogenic substrate MUNANA. N2 NAs are coloured according to the phylogenetic groups. Global test comparing the 4 groups was done using ANOVA (P= 2.4e-05) and pairwise comparison performed using Wilcoxon, ***P< 0.001, **P< 0.01, *P< 0.05. (b) Scatter-plot and correlation between the KM values and dilutions required to obtain 70% max activity in ELLA.
Antigenic relationship between NA of the H6N2 viruses.
(a) Hierarchical clustering based on multisampling and multiscale bootstrap resampling. Approximately unbiased p-values (AU) are shown in red, bootstrap values in green, and edge values in grey. The red brackets represent the clusters with AU > 95%. (b) K-means clustering represented using principal component analysis (k=4).
Antigenic map of N2 NAs.
Antigen and sera distances are represented in the graph and coloured according to distinct phylogenetic groups. The spacing between grid lines is 1 unit of antigenic distance corresponding to a twofold dilution of immune serum in the NAI assay.
Correlation of NAI fold reduction and phylogenetic relatedness.
The scatter plots show the phylogenetic distances (y-axis) and Normalized NAI as fold reduction relative to the maximal inhibition [log2 (max NAI/NAI)] (x-axis). Each graph represents one of the 27 H6N2s that were tested.
Breadth of N2 inhibition of sera from ferrets primed by H1N2 infection only.
43 Heat-map representing the average of normalized neuraminidase inhibition per H6N2 [log2 (max NAI/NAI)] determined in ferret sera 2 weeks after infection. The red-to-blue scale indicates the fold reduction compared to the max NAI observed in ELLA against the H6N2 reassortants (listed at the bottom). UPGMA clustering of H6N2 inhibition profiles are shown on top of the heat map and coloured according to the phylogenetic groups.
Breadth of N2 inhibition is confirmed in mouse sera.
43 Heat-map representing the average of normalized neuraminidase inhibition per H6N2 [log2 (max NAI/NAI)] determined in mice sera after the boost (listed on the right). The red-to-blue scale indicates low-to-high NAI observed in ELLA against the H6N2 reassortants (listed at the bottom). UPGMA clustering of H6N2 inhibition profiles are shown on top of the heat map and coloured according to the phylogenetic groups. (b) Correlation of NAI between mice and ferrets. Scatter plot shows the normalized NAI as fold reduction from maximal inhibition [log2 (max NAI/NAI)] from ferrets (y-axis) versus mice (x-axis). The 7 H6N2s tested are indicated in the graphs.
Protein sequence alignment of N2 NACHO panel used for immunization.
The sequence of recombinant NA that was used for boosting ferrets or to prime/boost BALB/c mice was aligned starting from the HIS-tag, tetrabrachion and followed by NA head domain, as depicted on top of the sequences.
Geometrical distribution of amino acid substitutions in the N2 structure.
The surface and ribbon representation indicate the geometrical distribution of the amino acid substitutions that are present in the panel of 43 N2 NAs used as immunogens in the study. Substitutions are highlighted in red on the model structure of N2 from H2N2 (A/RI/5+/1957, PBD 4H53).
Association study was performed on data obtained from mouse sera.
(a) Association study performed for each H6N2 virus (listed at the bottom) to determine the probability of each variable amino acid (listed on the right) present in the panel of 43 NAs to impact NAI. The red-to-blue scale represents significance values (-log10P) associated with each variable amino acid.
Correlation of values obtained from the mouse sera panel and amino acid distances.
(a) Significance values (102 variable amino acids) obtained from the association study were correlated to the distance between every amino acid and each of the variable amino acids in the NA structure. The red-to-blue scale represents the Tau values obtained in the Kendall correlation. Amino acids 83 to 469 are shown from top to bottom of the heatmap. The H6N2s used in the NAI panel are listed at the bottom.
Specific activity of the recombinant NACHOs.
H6N2 reassortant viruses used in the ELLA assay.
NAI titers against H6N2 viruses of ferret sera obtained after the boost (Part I of II).
